Date published: 2026-4-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

Akt Activators

Akt activators encompass a range of compounds designed to enhance the activity of the serine/threonine-specific protein kinase Akt, also known as protein kinase B (PKB). Akt is central to many cellular processes, including metabolism, cell proliferation, apoptosis, and transcription. There are three isoforms of Akt, each with unique and overlapping functions within cellular signaling pathways. Activation of Akt typically requires phosphorylation, a process facilitated by interactions with upstream kinases like phosphoinositide-dependent kinase-1 (PDK1) and the mammalian target of rapamycin complex 2 (mTORC2). Akt activators operate by promoting this phosphorylation process, potentially by augmenting the interactions between Akt and its kinases or by stabilizing the phosphorylated form of Akt. The identification of Akt activators is achieved through high-throughput screening, seeking molecules capable of upregulating Akt activity. These candidate molecules are then subjected to a variety of biochemical assays, both in vitro and in cell-based systems, to validate their ability to enhance Akt phosphorylation and activation. Structure-activity relationship (SAR) studies are integral to this phase, as they provide insight into how structural changes to the molecule affect its activator function.To refine these activators, researchers delve into the molecular intricacies of how these compounds interact with the Akt kinase domain. Techniques such as X-ray crystallography can reveal the activators' binding modes, offering clues on how they might stabilize Akt's active conformation. These structural insights guide medicinal chemists in synthesizing analogues with optimized features, including potency and selectivity for Akt. Complementary biophysical methods like surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) are employed to assess binding affinities and kinetics. Through such detailed analyses, Akt activators are developed as precise tools for dissecting Akt's involvement in various cellular pathways, contributing to a broader understanding of its role in the complex signaling networks that regulate cell behavior. These compounds are particularly useful for examining the multifaceted roles of Akt and the delicate balance of kinase activity that is crucial for cellular homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fumonisin B1

116355-83-0sc-201395
sc-201395A
1 mg
5 mg
$200.00
$680.00
18
(1)

Fumonisin B1 acts as a competitive inhibitor of ceramide synthase, disrupting sphingolipid metabolism. Its unique structure allows for specific interactions with lipid membranes, influencing cellular signaling pathways. The compound's hydrophilic and hydrophobic regions facilitate its integration into biological systems, affecting membrane fluidity and permeability. This duality enhances its reactivity with various biomolecules, leading to altered cellular responses and metabolic dysregulation.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$156.00
$1248.00
$12508.00
82
(1)

Insulin activates the PI3K/AKT signaling pathway, which could lead to an increase in AKT1 expression as part of a feedback mechanism.

Bis(pinacolato)diboron

73183-34-3sc-252467
sc-252467A
1 g
5 g
$44.00
$82.00
(0)

PDGF can activate PI3K/AKT signaling, which might result in enhanced AKT1 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

While LY294002 is a PI3K inhibitor, it could lead to compensatory mechanisms in the cell that may upregulate AKT1 expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Similar to LY294002, wortmannin inhibition of PI3K may cause feedback that induces AKT1 expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibiting mTOR with rapamycin can result in feedback loops that could increase AKT1 expression due to loss of feedback inhibition.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Metformin activates AMPK, which can have complex effects on the PI3K/AKT pathway and may alter AKT1 expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol influences several signaling pathways and might affect AKT1 expression through its action on sirtuins and PI3K/AKT.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin modulates various molecular targets and could affect AKT1 expression through its anti-inflammatory effects and interaction with the PI3K/AKT pathway.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Caffeine impacts multiple signaling pathways and might affect AKT1 expression through its effects on cyclic AMP and cellular metabolism.